Literature DB >> 29106031

Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension.

Takeshi Fujiwara1,2, Satoshi Hoshide1, Yuichiro Yano3, Hiroshi Kanegae4, Kazuomi Kario1.   

Abstract

The aim of this study was to compare the effect of morning and bedtime administration of valsartan/amlodipine combination therapy (80/5 mg) on nocturnal brachial and central blood pressure (BP) measured by ambulatory BP monitoring in patients with hypertension. This was a 16-week prospective, multicenter, randomized, open-label, crossover, noninferiority clinical trial. Patients underwent 24-hour ambulatory BP monitoring at randomization, at switching, and at the end of the study. Twenty-three patients (mean age, 68.0 years) were studied. The difference in nocturnal brachial systolic BP between the morning and bedtime administrations of combination valsartan/amlodipine was -3.2 mm Hg, and the two-sided 95% confidence interval ranged from -6.8 to 0.4 mm Hg. The difference in nocturnal central systolic BP was -4.0 mm Hg (95% confidence interval, -7.6 to -0.4 mm Hg). The upper limit of the 95% confidence interval was below the margin of 3.0 mm Hg in both nocturnal brachial and central systolic BP, confirming the noninferiority of morning administration to the bedtime administration of valsartan/amlodipine combination therapy. ©2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  amlodipine; bedtime administration; clinical trial; crossover; morning administration; nocturnal central blood pressure; noninferiority; valsartan

Mesh:

Substances:

Year:  2017        PMID: 29106031      PMCID: PMC8030911          DOI: 10.1111/jch.13128

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  37 in total

1.  THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS.

Authors:  J E GRIZZLE
Journal:  Biometrics       Date:  1965-06       Impact factor: 2.571

2.  Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.

Authors:  Bryan Williams; Peter S Lacy; Simon M Thom; Kennedy Cruickshank; Alice Stanton; David Collier; Alun D Hughes; H Thurston; Michael O'Rourke
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

3.  Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients.

Authors: 
Journal:  Blood Press Monit       Date:  1998-02       Impact factor: 1.444

4.  Treatment of non-dipper hypertension with bedtime administration of valsartan.

Authors:  Ramón C Hermida; Carlos Calvo; Diana E Ayala; José R Fernández; Manuel Covelo; Artemio Mojón; José E López
Journal:  J Hypertens       Date:  2005-10       Impact factor: 4.844

5.  Association of home and ambulatory blood pressure changes with changes in cardiovascular biomarkers during antihypertensive treatment.

Authors:  Yuichirou Yano; Satoshi Hoshide; Motohiro Shimizu; Kazuo Eguchi; Joji Ishikawa; Shizukiyo Ishikawa; Kazuyuki Shimada; Kazuomi Kario
Journal:  Am J Hypertens       Date:  2011-12-15       Impact factor: 2.689

6.  Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients.

Authors:  Cesare Cuspidi; Stefano Meani; Laura Lonati; Veronica Fusi; Cristiana Valerio; Carla Sala; Gaia Magnaghi; Meilikemu Maisaidi; Alberto Zanchetti
Journal:  J Hypertens       Date:  2006-04       Impact factor: 4.844

7.  Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan.

Authors:  Derek Weycker; Abdulkadir Keskinaslan; Drew Griffin Levy; John Edelsberg; Alex Kartashov; Gerry Oster
Journal:  Blood Press Suppl       Date:  2008-12

8.  The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening.

Authors:  T Mengden; B Binswanger; T Spühler; B Weisser; W Vetter
Journal:  J Hypertens       Date:  1993-12       Impact factor: 4.844

9.  Optimal timing for antihypertensive dosing: focus on valsartan.

Authors:  Ramón C Hermida; Diana E Ayala; Carlos Calvo
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

10.  Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension.

Authors:  Takeshi Fujiwara; Satoshi Hoshide; Yuichiro Yano; Hiroshi Kanegae; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-11-05       Impact factor: 3.738

View more
  6 in total

Review 1.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

2.  A randomized multicenter study on ambulatory blood pressure and arterial stiffness in patients treated with valsartan/amlodipine or nifedipine GITS.

Authors:  Shao-Kun Xu; Qi-Fang Huang; Wei-Fang Zeng; Chang-Sheng Sheng; Yan Li; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-24       Impact factor: 3.738

3.  Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia Network.

Authors:  Kazuomi Kario; Jinho Shin; Chen-Huan Chen; Peera Buranakitjaroen; Yook-Chin Chia; Romeo Divinagracia; Jennifer Nailes; Satoshi Hoshide; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Yuda Turana; Yuqing Zhang; Sungha Park; Huynh Van Minh; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09       Impact factor: 3.738

Review 4.  Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network.

Authors:  Kazuomi Kario; Satoshi Hoshide; Yook-Chin Chia; Peera Buranakitjaroen; Saulat Siddique; Jinho Shin; Yuda Turana; Sungha Park; Kelvin Tsoi; Chen-Huan Chen; Hao-Min Cheng; Takeshi Fujiwara; Yan Li; Van Minh Huynh; Michiaki Nagai; Jennifer Nailes; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Jam Chin Tay; Boon Wee Teo; Narsingh Verma; Tzung-Dau Wang; Yuqing Zhang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-14       Impact factor: 3.738

Review 5.  Clinical significance of nocturnal home blood pressure monitoring and nocturnal hypertension in Asia.

Authors:  Takeshi Fujiwara; Satoshi Hoshide; Naoko Tomitani; Hao-Min Cheng; Arieska Ann Soenarta; Yuda Turana; Chen-Huan Chen; Huynh Van Minh; Guru Prasad Sogunuru; Jam Chin Tay; Tzung-Dau Wang; Yook-Chin Chia; Narsingh Verma; Yan Li; Ji-Guang Wang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-16       Impact factor: 3.738

6.  Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension.

Authors:  Takeshi Fujiwara; Satoshi Hoshide; Yuichiro Yano; Hiroshi Kanegae; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-11-05       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.